These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37448402)

  • 41. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
    Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.
    Del Rivero J; Donahue RN; Marté JL; Gramza AW; Bilusic M; Rauckhorst M; Cordes L; Merino MJ; Dahut WL; Schlom J; Gulley JL; Madan RA
    Front Endocrinol (Lausanne); 2020; 11():490. PubMed ID: 32849281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic analysis of a hereditary medullary thyroid carcinoma case with normal preoperative serum calcitonin levels.
    Zhang G; Jiang Y; Zhang S; Zhao L; Fan J; Zhang Z; Ma J; Chen R; Xu Y
    Pathol Res Pract; 2019 Oct; 215(10):152529. PubMed ID: 31409511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective study on the clinical relevance of
    Califano I; Pitoia F; Chirico R; De Salazar A; Bastianello MJ
    Endocrine; 2022 Jun; 77(1):143-150. PubMed ID: 35489000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of tumour biomarkers in choosing the appropriate positron emission tomography imaging in follow-up of medullary thyroid cancer.
    Şahin E; Elboğa U
    J Med Imaging Radiat Oncol; 2020 Dec; 64(6):756-761. PubMed ID: 32656989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy.
    Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
    Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
    Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
    Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small cell medullary thyroid carcinoma: A diagnostic dilemma.
    Verma A; Kane S; Vinarkar S; D'Cruz AK
    Indian J Pathol Microbiol; 2017; 60(4):562-564. PubMed ID: 29323074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ProGRP AS A NOVEL BIOMARKER FOR THE DIFFERENTIAL DIAGNOSIS OF MEDULLARY THYROID CARCINOMA IN PATIENTS WITH THYROID NODULES.
    Liang X; Zhu J; Cai M; Dai Z; Fang L; Chen H; Yu L; Lin Y; Lin E; Wu G
    Endocr Pract; 2020 May; 26(5):514-522. PubMed ID: 32045291
    [No Abstract]   [Full Text] [Related]  

  • 50. Pycnodysostosis with novel gene mutation and sporadic medullary thyroid carcinoma: A case report.
    Shi X; Huang C; Xiao F; Liu W; Zeng J; Li X
    Medicine (Baltimore); 2017 Dec; 96(50):e8730. PubMed ID: 29390266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mixed medullary-papillary carcinoma of the thyroid with lymph node metastases: report of a case.
    Shiroko T; Yokoo N; Okamoto K; Kitakado Y; Azuma H; Fukui T; Tanaka C
    Surg Today; 2001; 31(4):317-21. PubMed ID: 11321340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
    Mendelsohn G; Wells SA; Baylin SB
    Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.
    Ahmed SR; Ball DW
    J Clin Endocrinol Metab; 2011 May; 96(5):1237-45. PubMed ID: 21346073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
    Murphy DC; Johnson SJ; Aspinall S
    Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
    Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
    Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
    Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A high level of carcinoembryonic antigen as initial manifestation of medullary thyroid carcinoma in a patient with subclinical hyperthyroidism.
    Akbulut S; Sogutcu N
    Int Surg; 2011; 96(3):254-9. PubMed ID: 22216705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
    Papapetrou PD; Polymeris A
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.